BridgeBio Pharma, Inc.· BBIO

🇺🇸 US · LargeBroad USNASDAQ

Healthcare Biotechnology Website

Price: $66.61
Day: -1.04%
Mkt Cap: $13.05B
52W Range: $48.78 – $93.42
Volume: 4.10M
Beta: 0.97

D55D FrameworkQuarterly Data

Holdings Analysis

Insider activity, institutional flows, and fund ownership.

Smart Money: 3.1 / 5 (Neutral), from 3 of 3 components
Institutions Q2 2026: 513 institutions hold; 258 added, 174 reduced
Insiders Q3 2026: no purchases, 11 sales ($18.5M)

Blog

stockoscope.com

BridgeBio Pharma, Inc.

BBIO|Healthcare|Biotechnology

Current price: $67

Smart Money

Dimension 5 of 5

Insider selling pace · Q3 2026

0.1x

quarter in progress, filings still arriving

Seller breadth · Q3 2026

4 sellers

vs 6.5 avg per quarter

Institutional net breadth · Q2 2026

+100

346 adding vs 246 reducing

Institutional ownership · Q2 2026

99.8%

513 institutions

Insider Selling Pace

Each quarter's selling vs this stock's own trailing 6-quarter average

Light <0.5xRoutineElevated >1.5xHeavy >3xBuying

Institutional Positions

Institutions adding above the line, reducing below, net as a line

NewIncreasedReducedClosedNet

Largest Institutional Holders, Q2 2026

By reported market value, and how each moved in the quarter

Holder

Change

JUPITER TOPCO LLC

14.1M

+100.0%

KOHLBERG KRAVIS ROBERTS & CO. L.P.

13.3M

-0.5%

FARALLON CAPITAL MANAGEMENT LLC

10.7M

+14.1%

BLACKROCK, INC.

10.3M

-28.0%

VIKING GLOBAL INVESTORS LP

9.9M

-16.4%

VANGUARD CAPITAL MANAGEMENT LLC

7.9M

+1.3%

ETF & Fund Activity, Q2 2026

How the covering funds split between buying, holding and selling

113

89 buying113 unchanged98 selling

299 funds held BBIO in Q2 2026, holding 62.3M shares between them, down 4.0% on the quarter.

Largest fund holders

SPDR SERIES TRUST1.5M sh

T. Rowe Price Equity Series, Inc.26.5K sh

Venerable Variable Insurance Trust17.7K sh

Notable Insider Transactions, Q3 2026

Largest open-market purchases and sales by value in the last eight quarters

Sale · May 12

KKR Genetic Disorder L.P.

$205.2M

Sale · Mar 5

KKR Genetic Disorder L.P.

$197.8M

Sale · Jun 27

VIKING GLOBAL INVESTORS LP

$154.0M

Insider transactions from SEC Form 4 filings; institutional holdings from quarterly 13F filings, which are reported with a lag and can overlap between filers. 13F: quarterly institutional holdings report · ETF: Exchange-Traded Fund

See the complete picture

The full 5D Framework: Business Quality · Peer Comparison · Valuation · Analyst Sentiment · Smart Money

Explore BBIO on stockoscope.com→

Generated September 21, 2026

For educational purposes only. Not financial advice. Data may be delayed or incomplete.

Smart Money Sentiment

BBIO Smart Money Sentiment Score

A weighted 1-5 sentiment score across three smart money signals.

Smart Money

3.1/5

Neutral

Weighted across 3 components

Component Breakdown (3 of 3 available)

Insider Activity

40% weight

Institutional Flow

50% weight

+12

Fund Flow

10% weight

Overall Smart Money sentiment of 3.1/5 (Neutral) based on a weighted combination of 3 components. Insider activity uses a relative-baseline comparison against the stock's own history; institutional flow tracks position momentum and 13F share changes; fund flow measures ETF / mutual-fund buying vs selling. Higher scores indicate stronger bullish sentiment from professional investors.Last updated September 20, 2026.

Insider Trading Activity

Insider trading analysis comparing the latest quarter against the stock's own historical baseline.

Insider Selling Pace for BBIO

Each quarter's selling vs the stock's own trailing 6-quarter average; 1.0x is typical for this stock. Green triangles mark quarters with insider buying.

Neutral

Routine insider selling in Q3 2026

11 sales totaling $18.5M (212.7K shares)

Share volume is well below the historical pace (0.1x average), insiders are holding more

4 different insiders sold this quarter

Sell-only pattern: no insider purchases across 15 quarters

Steady selling pace across recent quarters

0.1x

Selling pace

quarter in progress, filings still arriving

0.32%

Stake sold

of active insiders' holdings

4 sellers

Seller breadth

vs 6.5 avg per quarter

None

Insider buying

in the last 16 quarters

Notable Recent Transactions, BBIO

Top 8 highest-value insider trades from the last 8 quarters

KKR Genetic Disorder L.P.

10% Owner

Sell

6,000,000 shares at $34.20

≈31.2% of their stake at the time

May 12, 2025$205.20M

KKR Genetic Disorder L.P.

10% Owner

Sell

6,000,000 shares at $32.96

≈23.8% of their stake at the time

Mar 5, 2025$197.76M

VIKING GLOBAL INVESTORS LP

10% Owner

Sell

3,500,000 shares at $44.00

≈15.9% of their stake at the time

Jun 27, 2025$154.00M

VIKING GLOBAL INVESTORS LP

10% Owner

Sell

3,065,616 shares at $34.90

≈12.2% of their stake at the time

Jan 31, 2025$106.99M

Kumar Neil

CEO

Sell

326,932 shares at $36.29

≈5.7% of their stake at the time

Jan 28, 2025$11.86M

Cook Jennifer E.

Director

Sell

112,422 shares at $90.00

≈93.1% of their stake at the time

Jul 9, 2026$10.12M

Kumar Neil

CEO

Sell

269,068 shares at $36.34

≈5.0% of their stake at the time

Jan 29, 2025$9.78M

HOMCY CHARLES J

Director

Sell

191,662 shares at $45.87

≈15.8% of their stake at the time

Aug 8, 2025$8.79M

Institutional Ownership Analysis

Institutional ownership analysis with position momentum, 13F share flow, and ownership percentage trends.

Institutional Positions for BBIO

Institutions adding (new + increased) above zero, reducing (reduced + closed) below, net as a line

New Increased Reduced Closed Net (adding − reducing)

Neutral

Mixed institutional activity in Q2 2026

99.8% institutional ownership

Slight accumulation: 346 adding vs 246 reducing

13F share count essentially flat

Momentum weakening from prior quarter

+100

Net breadth

346 adding vs 246 reducing

Accumulating

1.41

Add / reduce ratio

in Q2 2026

+16

New − closed

88 initiated, 72 exited

5 of 10

Top holders adding

largest holders with a known change

Position Changes

Q2 2026: how are institutions adjusting their positions?

+346 growing-246 shrinkingNet: +100

258

174

New (88)

Increased (258)

Reduced (174)

Closed (72)

Top Institutional Holders, BBIO

Largest 8 institutional positions by ownership percentage as of Q2 2026

JUPITER TOPCO LLC

14.1M

$1.1B

Ownership

7.21%

+100.0%

KOHLBERG KRAVIS ROBERTS & CO. L.P.

13.3M

$987.7M

Ownership

6.77%

-0.5%

FARALLON CAPITAL MANAGEMENT LLC

10.7M

$800.1M

Ownership

5.49%

+14.1%

BLACKROCK, INC.

10.3M

$766.2M

Ownership

5.25%

-28.0%

VIKING GLOBAL INVESTORS LP

9.9M

$741.0M

Ownership

5.08%

-16.4%

VANGUARD CAPITAL MANAGEMENT LLC

7.9M

$588.3M

Ownership

4.03%

+1.3%

VANGUARD PORTFOLIO MANAGEMENT LLC

7.7M

$570.3M

Ownership

3.91%

-5.7%

WELLINGTON MANAGEMENT GROUP LLP

5.3M

$395.4M

Ownership

2.71%

+112.6%

ETF and Mutual Fund Holdings

ETF and mutual fund activity breakdown showing buying vs selling funds, top fund holders, and detailed holdings.

Fund Activity

Q2 2026: 300 ETFs and mutual funds reporting

89 buying98 sellingNet: -9

113

Buying (89)

Unchanged (113)

Selling (98)

In total, funds bought 5.6M shares and sold 8.1M this quarter. Each fund counts once in the bar above, whatever the size of its move.

Neutral

Mixed fund activity in Q2 2026

300 ETFs and mutual funds reporting

89 buying vs 98 selling (balanced)

Top Fund Holders, BBIO

Largest 8 ETF and mutual fund positions by shares held, each fund's latest filing

SPDR SERIES TRUST

1.5M

Weight

7.31%

Jul 31, 2026No change

T. Rowe Price Equity Series, Inc.

26.5K

Weight

1.59%

Jun 30, 2026Decreased

Venerable Variable Insurance Trust

17.7K

Weight

0.03%

Jun 30, 2026Decreased

NATIONWIDE MUTUAL FUNDS

16.0K

Weight

0.00%

Jul 31, 2026No change

Voya PARTNERS INC

12.3K

Weight

0.02%

Jun 30, 2026Decreased

GABELLI ASSET FUND

8.6K

Weight

1.83%

Jun 30, 2026No change

Voya INVESTORS TRUST

8.2K

Weight

0.02%

Jun 30, 2026Decreased

BlackRock Health Sciences Trust

7.9K

Weight

2.62%

Jun 30, 2026Decreased

BridgeBio Pharma, Inc.· BBIO

Holdings Analysis

Insider Trading Activity

1.3Transaction History242Real market purchases and sales onlyShow All Types

Institutional Ownership Analysis

2.4Detailed Holdings145Most recent institutional positions with changes and valuations

ETF and Mutual Fund Holdings

3.3Fund Holdings Details25Most recent ETF and mutual fund holdings with share counts and weights

Search stocks

Holdings Analysis

Insider Trading Activity

1.3Transaction History242Real market purchases and sales onlyShow All Types

Institutional Ownership Analysis

2.4Detailed Holdings145Most recent institutional positions with changes and valuations

ETF and Mutual Fund Holdings

3.3Fund Holdings Details25Most recent ETF and mutual fund holdings with share counts and weights